article · BMC Complementary Medicine and Therapies
BACKGROUND: Medicinal plants are potential sources for developing novel antibiotics due to the declining effectiveness and associated side effects of synthetic drugs. This study aimed to evaluate the antibacterial and antifungal activities of 80% methanol crude extract and hexane, chloroform, butanol, and aqueous fractions of Suregada procera. METHODS: The dried roots of Suregada procera were macerated with 80% methanol and successively fractionated using hexane, chloroform, butanol, and aqueous solvents. The antibacterial and antifungal activities of both crude extract and the fractions were determined using agar well diffusion and broth dilution methods. One-way analysis of variance was used to analyze the data, followed by Tukey's post-hoc test. Ciprofloxacin 5 µg and amphotericin B 12.5 µg served as positive controls, while 1% dimethyl sulfoxide (DMSO) served as the negative control. RESULTS: The Suregada procera crude extract exhibited the largest zone of inhibition (12.67 ± 0.33) against Staphylococcus epidermidis and Trichophyton mentagrophytes at 200 mg/mL. Among the six bacterial strains, Enterococcus faecalis was the most susceptible to hexane and aqueous fractions at 0.33 mg/mL. In contrast, the butanol fraction exhibited the highest inhibitory activity against Trichophyton mentagrophytes at 0.5 mg/mL. CONCLUSION: The results of the present study support the traditional use of Suregada procera against bacterial and fungal pathogens.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12906-026-05466-4
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.